Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profound N-glycan remodelling accompanies MHC-II immunopeptide presentation. | Front Immunol | 2023 | 38022636 | PubTator, text mining | PubMed |
| The oncogenic role of NOTCH1 as biomarker in oral squamous cell carcinoma and oral lichen planus. | Dent Res J (Isfahan) | 2023 | 38020255 | PubTator, text mining | PubMed |
| How to Choose the Right Treatment for Membranous Nephropathy. | Medicina (Kaunas) | 2023 | 38004046 | PubTator, text mining | PubMed |
| In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced. | J Pers Med | 2023 | 38003890 | PubTator, text mining | PubMed |
| Base-Excision Repair Mutational Signature in Two Sebaceous Carcinomas of the Eyelid. | Genes (Basel) | 2023 | 38002998 | PubTator, text mining | PubMed |
Multigene Profiling of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma Identifies Prognostic Cancer Driver Genes Associated with Epithelial-Mesenchymal-Transition Progression and Chemoresistance. | Cancers (Basel) | 2023 | 38001588 | PubTator, text mining | PubMed |
| Assessment of axial spondyloarthritis activity using a magnetic resonance imaging-based multi-region-of-interest fusion model. | Arthritis Res Ther | 2023 | 38001465 | PubTator, text mining | PubMed |
| Identification of key biomarkers in RF-negative polyarticular and oligoarticular juvenile idiopathic arthritis by bioinformatic analysis. | Pediatr Rheumatol Online J | 2023 | 38001449 | PubTator, text mining | PubMed |
| Liquid Biopsy in Head and Neck Cancer: Its Present State and Future Role in Africa. | Cells | 2023 | 37998398 | PubTator, text mining | PubMed |
| Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group. | Cancer Med | 2023 | 37997571 | PubTator, text mining | PubMed |
| The potential of BRD4 inhibition in tumour mechanosignaling. | J Cell Mol Med | 2023 | 37994501 | PubTator, text mining | PubMed |
| Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective. | Cancer Cell Int | 2023 | 37993909 | PubTator, text mining | PubMed |
| Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease. | Sci Rep | 2023 | 37993474 | PubTator, text mining | PubMed |
| ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer. | Sci Adv | 2023 | 37992168 | PubTator, text mining | PubMed |
| Revealing the potential of necroptosis-related genes in prognosis, immune characteristics, and treatment strategies for head and neck squamous cell carcinoma. | Sci Rep | 2023 | 37989855 | PubTator, text mining | PubMed |
| The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response. | Cancer Med | 2023 | 37986697 | PubTator, text mining | PubMed |
| Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma. | Cancer Med | 2023 | 37986681 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors. | Nat Commun | 2023 | 37980418 | PubTator, text mining | PubMed |
| Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact, FDA Approval, and Resistance Pathways. | J Pharm Technol | 2023 | 37974598 | PubTator, text mining | PubMed |
| Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis. | J Gastrointest Oncol | 2023 | 37969819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=24